ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Prevelance of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 1997; 8: 66-70)
Effect of omeprazole, claritomycine and amoxiciline therapy on duodenal ulcer and Helicobacter pylori eradication
(Turk J Gastroenterol 1997; 8: 71-73)
Determination of primary resistance of Helicobacter pylori isolates to clarithromycin and amoxicilin by disc difussion method and the comparison with resistance in recurrent cases
(Turk J Gastroenterol 1997; 8: 309-312)
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 23-28)
DOI: 10.4318/tjg.2010.0043
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Immunohistochemical analysis of Ki-67, p53 and Bcl-2 expression related to histological features in gastroesophageal reflux disease
(Turk J Gastroenterol 2010; 21: 199-205)
DOI: 10.4318/tjg.2010.0088
Efficacy of probiotics in Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2010; 21: 212-217)
DOI: 10.4318/tjg.2010.0090
Effectiveness of different treatment regimens in helicobacter pylori eradication: Ten-year experience of a single institution
(Turk J Gastroenterol 2010; 21: 218-223)
DOI: 10.4318/tjg.2010.0091
Risk of Helicobacter pylori infection in newborn babies of Helicobacter pylori-positive pregrant woman
(Turk J Gastroenterol 1998; 9: 36-39)
One-week triple her therapies for Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 40-45)
Duodenal ulcer healing with one week therapy
(Turk J Gastroenterol 1998; 9: 46-49)
Helicobacter pylori and cobalamin deficiency
(Turk J Gastroenterol 1998; 9: 126-132)
The role of gastric juice ammonia and gastric huice urea nitrogen/ammonia in the diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 1998; 9: 133-137)
Helicobacter pylori seroprevalence in children, aged 6 months to 5 years old, in Turkey
(Turk J Gastroenterol 1998; 9: 138-145)
Recurrence rates after Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 154-158)
The type and localization of gastritis in patients with dudenal ulcer and relationship to helicobacter pylori
(Turk J Gastroenterol 1998; 9: 167-171)
Utility of esophageal manometry and pH-metry in gastroesophageal reflux disease before surgery
(Turk J Gastroenterol 2009; 20: 261-265)
DOI: 10.4318/tjg.2009.0023
The association of Helicobacter Pylori with gastric epithelial cell proliferation
(Turk J Gastroenterol 1998; 9: 349-353)
The comparsion of lansoprazole and omeprazole in the one-week triple therapy for the eradication of Helicobacter Pylori
(Turk J Gastroenterol 1998; 9: 354-357)
Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
(Turk J Gastroenterol 2008; 19: 146-151)
The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: An open-label pilot study
(Turk J Gastroenterol 2008; 19: 158-162)
Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey
(Turk J Gastroenterol 2008; 19: 163-167)
The relationship between cagA positivity and serum gastrin and TNF- alpha levels in patients with chronic active gastritis and duodenal ulcer associated with Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 385-390)
Gastro-esophageal reflux following Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 411-418)
Intragastric distribution of Helicobacter pylori after eradication therapy
(Turk J Gastroenterol 2000; 11: 20-24)
A comparison of lansoprazole and omeprazole based triple combinations for the treatment of Helicobacter pylori associated gastritis and peptic ulcer
(Turk J Gastroenterol 2000; 11: 25-29)
Helicobacter pylori and antibiotic resistance
(Turk J Gastroenterol 2000; 11: 141-145)
The effect of CagA status on response to Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2000; 11: 146-149)
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 2000; 11: 97-102)
Systemic cellular immune response in Helicobacter pylori associated duodenal ulcer and chronic antral gastritis
(Turk J Gastroenterol 2000; 11: 208-211)
Re-bleeding in patients following Helicobacter pylori eradication therapy for bleeding peptic ulcer:Results of 18 month-follow up
(Turk J Gastroenterol 2000; 11: 212-215)
The effects of alcohol on gastric mucosa and gastric emptying time
(Turk J Gastroenterol 2000; 11: 216-221)
Colonization of Helicobacter pylori–like organisms on the ectopic gastric mucosa of Meckel’s diverticulum:A case report*
(Turk J Gastroenterol 2000; 11: 264-266)
Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum?
(Turk J Gastroenterol 2004; 15: 86-89)
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy
(Turk J Gastroenterol 2004; 15: 90-93)
The relation of Helicobacter pylori with intestinal metaplasia, gastric atrophy and BCL-2
(Turk J Gastroenterol 2004; 15: 149-155)
*Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years in Turkey
(Turk J Gastroenterol 2004; 15: 156-158)
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests
(Turk J Gastroenterol 2004; 15: 159-163)
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori
(Turk J Gastroenterol 2004; 15: 219-224)
Predictive value of tissue cagA status in Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 27-31)
Does omeprazole alter the salivary gland functions?
(Turk J Gastroenterol 2001; 12: 113-116)
Can resistant Helicobacter pylori infection be estimated histologically: Effects of gastric histology on eradication rates of Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 126-129)
Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations
(Turk J Gastroenterol 2001; 12: 206-210)
Does Helicobacter pylori infection have a role in coronary artery disease?
(Turk J Gastroenterol 2001; 12: 287-293)
Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community
(Turk J Gastroenterol 2007; 18: 14-19)
Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran
(Turk J Gastroenterol 2007; 18: 165-171)
Seroprevalence of Helicobacter pylori in children with constitutional height retardation
(Turk J Gastroenterol 2006; 17: 7-12)
PCNA expression in chronic gastritis due to Helicobacter pylori*
(Turk J Gastroenterol 2006; 17: 84-89)
Bismuth-based therapies for the first step eradication of Helicobacter pylori
(Turk J Gastroenterol 2006; 17: 90-93)
Efficacy of combination therapy with omeprazole, amoxicillin and clarithromycin for treatment of patients with Helicobacter pylori associated gastritis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 27-31)
Evaluation of chronic gastritis in patients with Helicobacter pylori associated gastritis, gastroduodenitis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 32-35)
Helicobacter pylori infection in gastric carcinoma in the Van region of Turkey
(Turk J Gastroenterol 1999; 10: 36-39)
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
(Turk J Gastroenterol 2005; 16: 29-33)
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases
(Turk J Gastroenterol 2005; 16: 203-206)
Characteristics of gastroesophageal reflux disease in our country
(Turk J Gastroenterol 1999; 10: 101-106)
The effect of different dosage and duration of lansoprazole-clarithromycin- amoxycillin combination on Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 115-117)
Changes in the degree of gastritis during the treatment of duodenal ulcer
(Turk J Gastroenterol 1999; 10: 118-121)
Hypersensitive esophagus: can it be classified as a subgroup of gastroesophageal reflux disease?
(Turk J Gastroenterol 2002; 13: 24-30)
Detection of Helicobacter pylori using nested polymerase chain reaction and rapid urease test in gastric biopsy samples
(Turk J Gastroenterol 2002; 13: 94-97)
The relationship between Helicobacter pylori intensity and histopathological findings in cases with chronic gastritis and duodenal ulcer
(Turk J Gastroenterol 2002; 13: 98-102)
The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus
(Turk J Gastroenterol 2002; 13: 103-107)
The effect of Helicobacter pylori eradication on symptoms and gastric emptying in patients with nonulcer dyspepsia
(Turk J Gastroenterol 2002; 13: 146-153)
Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus
(Turk J Gastroenterol 2002; 13: 154-158)
Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors?
(Turk J Gastroenterol 2002; 13: 159-163)
The association of short segment Barrett's esophagus with intestinal metaplasia in stomach
(Turk J Gastroenterol 2003; 14: 33-38)
The researched of Helicobacter pylori incidence on Turkish population who have been living in Germany
(Turk J Gastroenterol 1996; 7: 61-64)
An effective and economic approach for the eradication of Helicobacter Pylori:omeprazole and two antibiotic combination
(Turk J Gastroenterol 1996; 7: 228-232)
Prevelance of Helicobacter pylori in patients with of without dyspepsia and comparsion of different methods in the diagnosis of helicobacter pylori
(Turk J Gastroenterol 1996; 7: 223-236)
Prevelance of helicobacter pylori infection among Turkish living in or near Stutgart Germany, and the effect of triple therapy (pantoprazole-clarithomycin-metronidzole) on Helicobacter pylori infection
(Turk J Gastroenterol 1996; 7: 237-239)
The effect of eradaicating helicobacter pylori infection on intragastric pH and serum gastrin concentrations
(Turk J Gastroenterol 1996; 7: 331-334)
Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer*
(Turk J Gastroenterol 2003; 14: 168-172)
The effect of duodenogastric reflux on Helicobacter pylori presence and gastric histopathologic changes
(Turk J Gastroenterol 2003; 14: 239-242)
The prevalence of lymphoid follicles and intestinal metaplasia in Helicobacter pylori associated clinically significant gastroduodenal diseases
(Turk J Gastroenterol 1999; 10: 197-201)
Ranitidine bismuth citrate based dual and triple therapies in Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 202-206)
Nitric oxide oxidation products in the serum of patients with gastric and esophageal cancer and Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 193-196)
Blind gastric biopsy in the diagnosis of Helicobacter Pylori infection
(Turk J Gastroenterol 1997; 8: 440-442)
Surgical management of perforated dudenal ulcers
(Turk J Gastroenterol 1997; 8: 447-453)
The importance of Candida in a cade with refactory duodenal ulcer
(Turk J Gastroenterol 1997; 8: 251-253)
Review
A proposed role for diffusible signal factors in the biofilm formation and morphological transformation of Helicobacter pylori
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2017.17349
How is gastroesophageal reflux disease classified?
(Turk J Gastroenterol 2017; 28: 10-11)
DOI: 10.5152/tjg.2017.04
To whom and when the upper gastrointestinal endoscopy is indicated in gastroesophageal reflux disease? What is the role of routine esophageal biopsy? Which endoscopic esophagitis classification should be used?
(Turk J Gastroenterol 2017; 28: 22-25)
DOI: 10.5152/tjg.2017.07
How should we describe, diagnose and observe the Barrett's esophagus?
(Turk J Gastroenterol 2017; 28: 26-30)
DOI: 10.5152/tjg.2017.08
Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
(Turk J Gastroenterol 2017; 28: 31-32)
DOI: 10.5152/tjg.2017.09
Which drugs are risk factors for the development of gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 38-43)
DOI: 10.5152/tjg.2017.11
Which diseases are risk factors for developing gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 44-47)
DOI: 10.5152/tjg.2017.12
What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
(Turk J Gastroenterol 2017; 28: 57-60)
DOI: 10.5152/tjg.2017.15
Gastroesophageal reflux disease and the relationship with Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 61-67)
DOI: 10.5152/tjg.2017.16
When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?
(Turk J Gastroenterol 2017; 28: 68-70)
DOI: 10.5152/tjg.2017.17
What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
(Turk J Gastroenterol 2017; 28: 71-72)
DOI: 10.5152/tjg.2017.18
Case Report
A case of endoscopic ultrasound diagnosis of gastric amyloidosis
(Turk J Gastroenterol 2012; 23: 769-772)
DOI: 10.4318/tjg.2012.0443
Original Article
Is there a relationship between Helicobacter pylori and gastric autoimmunity?
(Turk J Gastroenterol 2011; 22: 134-138)
DOI: 10.4318/tjg.2011.0181
Helicobacter pylori and histopathological findings in patients with dyspepsia
(Turk J Gastroenterol 2011; 22: 122-127)
DOI: 10.4318/tjg.2011.0179
Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: A population-based cross-sectional study
(Turk J Gastroenterol 2012; 23: 323-332)
DOI: 10.4318/tjg.2012.0352
Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa
(Turk J Gastroenterol 2012; 23: 212-219)
DOI: 10.4318/tjg.2012.0345
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori
(Turk J Gastroenterol 2012; 23: 8-13)
DOI: 10.4318/tjg.2012.0392
Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China
(Turk J Gastroenterol 2013; 24: 5-9)
DOI: 10.4318/tjg.2013.0525
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial
(Turk J Gastroenterol 2013; 24: 10-14)
DOI: 10.4318/tjg.2013.0540
Ongoing symptoms after eradication of Helicobacter pylori: Psychiatric disorders may accompany!
(Turk J Gastroenterol 2013; 24: 15-21)
DOI: 10.4318/tjg.2013.0582
Gastroesophageal reflux disease prevalence in the city of Sivas
(Turk J Gastroenterol 2013; 24: 303-310)
DOI: 10.4318/tjg.2013.0256
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 2013; 24: 316-321)
DOI: 10.4318/tjg.2013.0509
Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children
(Turk J Gastroenterol 2013; 24: 382-386)
DOI: 10.4318/tjg.2013.0575
In vitro effects of famotidine and ranitidine on lower esophageal sphincter tone in rats
(Turk J Gastroenterol 2012; 23: 438-443)
DOI: 10.4318/tjg.2012.0448
Evaluation of serum ghrelin levels in patients with hyperplastic gastric polyps
(Turk J Gastroenterol 2012; 23: 444-447)
DOI: 10.4318/tjg.2012.0424
Assessment of COX-2 expression presence and severity by immunohistochemical method in patients with chronic active gastritis and intestinal metaplasia
(Turk J Gastroenterol 2012; 23: 478-484)
DOI: 10.4318/tjg.2012.0432
Ineffective esophageal motility and gastroesophageal reflux disease: A close relationship?
(Turk J Gastroenterol 2012; 23: 627-633)
DOI: 10.4318/tjg.2012.0452
Gastroesophageal reflux in children with functional constipation
(Turk J Gastroenterol 2012; 23: 634-638)
DOI: 10.4318/tjg.2012.0454
The effect of narrowed segment length on the degree of early postoperative dysphagia in laparoscopic Nissen fundoplication
(Turk J Gastroenterol 2012; 23: 676-680)
DOI: 10.4318/tjg.2012.0487
Does Helicobacter pylori treatment improve the symptoms of globus hystericus?
(Turk J Gastroenterol 2012; 23: 681-685)
DOI: 10.4318/tjg.2012.0507
Typical symptoms rather than extraesophageal symptoms affect the quality of life in gastroesophageal reflux disease
(Turk J Gastroenterol 2012; 23: 747-752)
DOI: 10.4318/tjg.2012.0480
The diagnostic accuracy of urine IgG antibody tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients
(Turk J Gastroenterol 2012; 23: 753-758)
DOI: 10.4318/tjg.2012.0497
Non-erosive reflux disease compared with erosive esophagitis with regards to acid reflux and symptom patterns
(Turk J Gastroenterol 2011; 22: 464-471)
DOI: 10.4318/tjg.2011.0249
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients
(Turk J Gastroenterol 2011; 22: 569-574)
DOI: 10.4318/tjg.2011.0252
Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
(Turk J Gastroenterol 2011; 22: 582-586)
DOI: 10.4318/tjg.2011.0255
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey
(Turk J Gastroenterol 2011; 22: 249-254)
DOI: 10.4318/tjg.2011.0209
The role of interleukin-1 gene polymorphisms and Helicobacter pylori in gastroesophageal reflux disease
(Turk J Gastroenterol 2014; 25: 81-85)
DOI: 10.5152/tjg.2014.6512
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease
(Turk J Gastroenterol 2011; 22: 1-5)
DOI: 10.4318/tjg.2011.0148
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection
(Turk J Gastroenterol 2015; 26: 456-460)
DOI: 10.5152/tjg.2015.0233
Clinical characteristics and natural history of asymptomatic erosive esophagitis
(Turk J Gastroenterol 2014; 25: 248-252)
DOI: 10.5152/tjg.2014.5033
Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients
(Turk J Gastroenterol 2015; 26: 6-14)
DOI: 10.5152/tjg.2015.0010
Atrial fibrillation and sympathovagal balance in patients with gastroesophageal reflux disease
(Turk J Gastroenterol 2017; 28: 88-93)
DOI: 10.5152/tjg.2017.16540
Is there any association between colonic polyps and gastric intestinal metaplasia?
(Turk J Gastroenterol 2016; 27: 221-226)
DOI: 10.5152/tjg.2016.15212
Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer
(Turk J Gastroenterol 2016; 27: 227-232)
DOI: 10.5152/tjg.2016.15375
Decreasing prevalence of Helicobacter pylori according to birth cohorts in urban China
(Turk J Gastroenterol 2017; 28: 94-97)
DOI: 10.5152/tjg.2017.16557
Relationship between Helicobacter pylori infection and metabolic syndrome
(Turk J Gastroenterol 2015; 26: 468-473)
DOI: 10.5152/tjg.2015.0197
The importance of upper gastrointestinal endoscopy in morbidly obese patients
(Turk J Gastroenterol 2015; 26: 228-231)
DOI: 10.5152/tjg.2015.0083
Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study
(Turk J Gastroenterol 2017; 28: 104-109)
DOI: 10.5152/tjg.2016.0284
Gastrointestinal Tract - Original Article
Role of toll-like receptor 10 gene polymorphism and gastric mucosal pattern in patients with chronic gastritis
(Turk J Gastroenterol 2017; 28: 243-247)
DOI: 10.5152/tjg.2017.16673
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 30.11.2017